By Sara So, L.C.P.C.
Psychedelic experiences can be intense and unpredictable, leaving patients especially vulnerable. For people with a history of trauma, that vulnerability requires thoughtful care. That’s where trauma-informed care (TIC) comes in.
Trauma-informed care recognizes that traumatic experiences can have lasting effects on a person’s emotions, relationships, body, and sense of safety. It encourages providers to create conditions that promote safety, choice, trust, and a sense of control while reducing the risk of re-traumatization.
These principles are particularly important in psychedelic-assisted therapy.
What Is Psychedelic-Assisted Therapy?
Psychedelic-assisted therapy (PAT) combines a psychedelic substance with psychological support or psychotherapy. Depending on the treatment or research protocol, therapeutic approaches may include Acceptance and Commitment Therapy (ACT), Cognitive Behavioral Therapy (CBT), or other forms of psychotherapy.
PAT generally includes three stages:
-
Preparation. The patient and therapist build a therapeutic relationship, discuss what to expect, establish boundaries, and prepare for the emotional and physical effects of the psychedelic.
-
Dosing. The same therapist supports the patient during the psychedelic experience, helping maintain physical and psychological safety while encouraging an inner-directed experience.
-
Integration. Afterward, the patient and therapist process the experience, make sense of what emerged, and consider how insights from the session might be incorporated into everyday life.
The patient’s mindset, often called “set,” and the physical and interpersonal environment, known as “setting,” are important throughout psychedelic treatment.
In the United States, most psychedelics remain Schedule I controlled substances at the federal level, with ketamine being a notable exception. As a result, much PAT involving substances such as psilocybin and MDMA occurs within clinical research or other legally authorized settings. Clinical trials are standardized and time-limited, which can create additional challenges when tailoring care to an individual patient’s needs.
How Trauma Can Surface During Psychedelic Therapy
Trauma can result from a single overwhelming event or from repeated experiences over time. Complex trauma generally involves repeated or prolonged traumatic experiences, often within important relationships or involving caregivers or authority figures.
Trauma can emerge during any stage of psychedelic therapy, just as it can during traditional psychotherapy. Psychedelics add another layer because they can intensify emotions, memories, bodily sensations, and perceptions while changing a person’s usual sense of control.
A patient may experience fear, disorientation, helplessness, or difficult memories with unusual intensity. Trauma-informed care helps therapists prepare for these possibilities rather than simply react when distress occurs.
What Does Trauma-Informed Psychedelic Care Look Like?
Trauma-informed psychedelic care is an approach that shapes the entire therapeutic process. At its core, it means protecting patient agency, maintaining relational safety, respecting boundaries, and treating consent as an ongoing process.
Before a dosing session, for example, the therapist and patient might discuss grounding techniques that feel helpful, as well as words, behaviors, or interactions that could increase distress. Such conversations allow the patient to have a meaningful voice in their care before entering an altered state.
Preparation: Building Safety and Trust
Preparation can be particularly important for people with complex trauma because previous experiences may affect trust, relationships, and feelings of safety.
Trauma-informed preparation can include additional preparatory sessions, practicing grounding techniques, discussing how trauma can show up emotionally and physically, and creating a plan for managing distress during the dosing experience. When significant safety concerns arise, dosing may need to be delayed or canceled.
Planning for Supportive Touch
Patients may be unusually vulnerable during a psychedelic experience.
If supportive touch might be used as a grounding technique, the patient and therapist should discuss it beforehand. Examples could include hand-holding or placing a hand on the patient’s wrist, arm, shoulder, or upper back.
Consent should be specific and ongoing.
Alternatives can also be planned. A patient who does not want direct touch might prefer to hold one end of a cushion while the therapist holds the other, providing a sense of connection without physical contact.
Planning the possibilities in advance gives patients greater agency during a time when communicating their needs may become difficult.
Dosing: Maintaining Consent and Safety
During dosing, the therapist continues nurturing the relationship and safety planning established during preparation.
Because psychedelics can produce disorientation, vulnerability, or a reduced ability to make decisions, therapists need to remain attentive to both verbal communication and nonverbal cues.
For example, if supportive touch is being used and a patient suddenly tenses, becomes still, changes their breathing, pulls away, or stops speaking, the therapist should recognize that something may have changed. Previously given consent should not be treated as permanent permission. The therapist can stop, physically create space, and verbally explain what they are doing.
Clear boundaries, well-defined roles, ongoing consent, and careful attention to the patient’s responses help protect both physical and emotional safety.
Integration: Supporting What Happens Afterward
Trauma-informed care doesn’t end after the dosing session. Difficult emotions or trauma-related symptoms may emerge hours or days later.
During integration, the therapist helps the patient understand and respond to what surfaced during the experience. Support may include previously identified coping strategies such as breathing exercises, grounding practices, familiar routines, and trusted social support. If significant trauma-related symptoms emerge, additional integration sessions or specialized trauma-informed mental health treatment may be appropriate.
Ideally, these resources are identified during preparation so patients already know where they can turn if they need additional support.
A Framework for Safer Psychedelic Care
Trauma-informed care is more than a strategy for managing a difficult psychedelic experience. It is a framework for designing care throughout the process.
It asks therapists and care teams to consider safety, trust, consent, choice, boundaries, power, and individual needs at every stage, from preparation through dosing, integration, and aftercare.
Because psychedelic experiences can place people in unusually vulnerable states, understanding how trauma may interact with those experiences is essential. Incorporating trauma-informed principles throughout psychedelic-assisted therapy can create a safer therapeutic environment while helping patients maintain a sense of agency in their own care.
Sara So, L.C.P.C., is a psychotherapist with more than a decade of experience in academic research. They hold a Master of Health Science from Johns Hopkins University, a Master of Science from Loyola University Maryland, and a Bachelor of Arts from Pennsylvania State University. Prior to joining Sunstone Therapies, they served as a Psychiatric Therapist at the Center for Psychedelic and Consciousness Research at Johns Hopkins University.
